> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Priority Voucher Awarded to Siga Technologies
- URL: https://www.fdaweb.com/priority-voucher-awarded-to-siga-technologies/
- Published: 2019-04-02T12:00:00.000Z
- Updated: 2026-09-15T01:17:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143758

*Federal Register* notice: FDA has issued a priority review voucher to Siga Technologies for gaining approval of a material threat medical countermeasure product application. In awarding the voucher, the agency determined that Siga’s NDA for TPoxx (tecovirimat), indicated to treat human smallpox disease in adults and pediatric patients weighing at least 13 kilograms, met the criteria for the award. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-04-01/pdf/2019-06145.pdf?ref=fdaweb.com).